ZULATO, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.419
EU - Europa 1.042
AS - Asia 773
SA - Sud America 226
AF - Africa 210
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 13
Totale 3.707
Nazione #
US - Stati Uniti d'America 1.312
IT - Italia 376
SG - Singapore 273
DE - Germania 172
BR - Brasile 152
CN - Cina 137
FI - Finlandia 99
HK - Hong Kong 98
NL - Olanda 73
PL - Polonia 45
GB - Regno Unito 33
SE - Svezia 33
FR - Francia 32
IN - India 27
VN - Vietnam 26
AT - Austria 19
CI - Costa d'Avorio 17
RU - Federazione Russa 17
TR - Turchia 14
KR - Corea 13
AO - Angola 12
ID - Indonesia 12
AR - Argentina 11
CA - Canada 11
KH - Cambogia 11
GE - Georgia 10
IQ - Iraq 10
VE - Venezuela 10
BO - Bolivia 9
DK - Danimarca 9
DZ - Algeria 9
EC - Ecuador 9
ET - Etiopia 9
MA - Marocco 9
MX - Messico 9
AZ - Azerbaigian 8
CH - Svizzera 8
CV - Capo Verde 8
CW - ???statistics.table.value.countryCode.CW??? 8
IL - Israele 8
LC - Santa Lucia 8
MG - Madagascar 8
PH - Filippine 8
UA - Ucraina 8
YT - Mayotte 8
BG - Bulgaria 7
CL - Cile 7
CU - Cuba 7
CY - Cipro 7
GH - Ghana 7
HT - Haiti 7
JP - Giappone 7
MD - Moldavia 7
PY - Paraguay 7
TW - Taiwan 7
UY - Uruguay 7
ZM - Zambia 7
BA - Bosnia-Erzegovina 6
BJ - Benin 6
BW - Botswana 6
BZ - Belize 6
CO - Colombia 6
DJ - Gibuti 6
ES - Italia 6
GM - Gambi 6
GR - Grecia 6
HR - Croazia 6
IR - Iran 6
JM - Giamaica 6
LB - Libano 6
MK - Macedonia 6
MY - Malesia 6
PA - Panama 6
PG - Papua Nuova Guinea 6
PK - Pakistan 6
PT - Portogallo 6
RS - Serbia 6
SA - Arabia Saudita 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
UG - Uganda 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
BD - Bangladesh 5
BE - Belgio 5
BS - Bahamas 5
CG - Congo 5
EG - Egitto 5
HU - Ungheria 5
IS - Islanda 5
KG - Kirghizistan 5
LA - Repubblica Popolare Democratica del Laos 5
MU - Mauritius 5
NP - Nepal 5
PE - Perù 5
SI - Slovenia 5
SN - Senegal 5
TH - Thailandia 5
TJ - Tagikistan 5
TN - Tunisia 5
Totale 3.521
Città #
Chandler 183
Ashburn 176
Singapore 149
Fairfield 124
Munich 121
Hong Kong 91
Santa Clara 65
Helsinki 64
Houston 61
Cambridge 51
Milan 45
Padova 44
Seattle 38
Beijing 37
Boardman 30
San Diego 30
Woodbridge 30
New York 28
Bytom 27
Rome 26
Ann Arbor 24
Wilmington 24
Los Angeles 21
Chicago 20
Hefei 19
Medford 19
Princeton 19
Abidjan 17
São Paulo 17
Des Moines 16
Turku 15
Ho Chi Minh City 13
Seoul 12
Lappeenranta 11
Warsaw 11
Council Bluffs 10
London 10
Nuremberg 10
Phnom Penh 10
Cagliari 9
Luanda 9
Naples 9
Antananarivo 8
Baku 8
Castries 8
Frankfurt am Main 8
Redondo Beach 8
Roxbury 8
Addis Ababa 7
Florence 7
Havana 7
Lusaka 7
Palermo 7
Praia 7
Pune 7
Vienna 7
Willemstad 7
Djibouti 6
Kampala 6
Montevideo 6
Panama City 6
Port Moresby 6
Tbilisi 6
Bishkek 5
Brooklyn 5
Buffalo 5
Casablanca 5
Catania 5
Cotonou 5
Dakar 5
Dallas 5
Dushanbe 5
Falkenstein 5
Fort Liberté 5
Gaborone 5
George Town 5
Guayaquil 5
Hanoi 5
Jyväskylä 5
La Paz 5
Mamoudzou 5
Montreal 5
Ogden 5
Venice 5
Accra 4
Amman 4
Andorra la Vella 4
Apia 4
Athens 4
Baghdad 4
Banjul 4
Boston 4
Brasília 4
Brazzaville 4
Bridgetown 4
Brisbane 4
Carmiano 4
Conakry 4
Damascus 4
Foggia 4
Totale 2.061
Nome #
CARATTERIZZAZIONE GENETICA E FUNZIONALE DI FIBROBLASTI ISOLATI DA PAZIENTI AFFETTI DA SINDROME DI ALSTROM 328
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 286
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 213
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 183
LKB1 expression correlates with increased survival in advanced non-small cell lung cancer patients treated with chemotherapy and bevacizumab 162
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer 157
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 154
Involvement of NADPH Oxidase 1 in Liver Kinase B1-mediated effects on tumor angiogenesis and growth 146
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors 146
Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy 133
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features 131
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective 128
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach 124
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 115
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer 114
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers 113
Implementation of next generation sequencing-based liquid biopsy for clinical molecular diagnostics in non-small cell lung cancer (Nsclc) patients 109
EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience 107
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: Predictive value of DNA-PK and phosphorylated ACC 107
null 107
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? 106
Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC 104
Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by diverse growth factors 103
Aspirin-triggered DHA metabolites inhibit angiogenesis 89
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC 87
Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancer 70
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer 60
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 55
Detection of loss of heterozygosity in cfDNA of advanced EGFR-or KRAS-mutated non-small-cell lung cancer patients 9
Totale 3.746
Categoria #
all - tutte 13.183
article - articoli 12.336
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 6 10 3 17 8 20 35 22 11
2021/2022355 14 21 23 16 35 33 74 25 14 12 32 56
2022/2023342 45 45 26 58 37 42 5 16 39 7 20 2
2023/2024314 11 28 31 21 20 57 25 27 21 22 30 21
2024/20251.193 17 61 67 50 129 64 92 122 134 50 160 247
2025/20261.282 214 262 425 381 0 0 0 0 0 0 0 0
Totale 3.746